Claire Fraser's Net Worth

$6.87 Million

Estimate Recalculated Dec 3, 2024 10:52PM EST

Who is Claire Fraser

Claire Fraser has an estimated net worth of $6.87 Million. This is based on reported shares across multiple companies, which include BECTON DICKINSON & CO, Seres Therapeutics, Inc., and HELICOS BIOSCIENCES CORP.

SEC CIK

Claire Fraser's CIK is 0001382031

Past Insider Trading and Trends

2023 was Claire Fraser's most active year for acquiring shares with 3 total transactions. Claire Fraser's most active month to acquire stocks was the month of December. 2020 was Claire Fraser's most active year for disposing of shares, totalling 3 transactions. Claire Fraser's most active month to dispose stocks was the month of January. 2024 saw Claire Fraser paying a total of $0.00 for 60,900 shares, this is the most they've acquired in one year. In 2019 Claire Fraser cashed out on 1,429 shares for a total of $347,618.54, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BECTON DICKINSON & CO

Investor
Updated Aug 08, 2025
Form 4
-3.59%
-863.00
$192.30
-$165.95K
Aug 08, 2025
23.14K
Sale
Aug 08
Form 4
4.13%
900.00
Jan 25, 2024
22.70K
Grant
Jan 23
Form 4
-3.78%
-848.00
$281.66
-$238.85K
Aug 30, 2023
21.61K
Sale
Aug 28
Form 4
3.95%
848.00
Jan 26, 2023
22.31K
Grant
Jan 26
Form 4
-3.75%
-841.00
$271.70
-$228.50K
Feb 10, 2022
21.56K
Sale
Feb 08
Form 4
3.80%
820.00
Jan 27, 2022
22.40K
Grant
Jan 25
Form 4
-1.88%
-387.00
$251.58
-$97.36K
Aug 18, 2021
20.22K
Sale
Aug 18
Form 4
-1.86%
-390.00
$241.36
-$94.13K
May 28, 2021
20.61K
Sale
May 27
Form 4
4.11%
829.00
Jan 28, 2021
21.00K
Grant
Jan 26
Form 4
-3.68%
-771.00
$256.56
-$197.81K
May 08, 2020
20.17K
Sale
May 08
Form 4
-6.68%
-1.50K
$258.72
-$388.07K
Feb 11, 2020
20.94K
Sale
Feb 11
Form 4
3.53%
765.00
Jan 30, 2020
22.44K
Grant
Jan 28
Form 4
-6.22%
-1.43K
$243.26
-$347.62K
Aug 07, 2019
21.54K
Sale
Aug 07
Form 4
4.21%
923.00
Jan 24, 2019
22.84K
Grant
Jan 22
Form 4
4.55%
941.00
Jan 25, 2018
21.64K
Grant
Jan 23
Form 4
6.15%
1.18K
Jan 26, 2017
20.39K
Grant
Jan 24
Form 4
7.31%
1.27K
Jan 29, 2016
18.60K
Grant
Jan 26
Form 4
8.41%
1.34K
Jan 29, 2015
17.33K
Grant
Jan 27
Form 4
11.33%
1.60K
Jan 30, 2014
15.70K
Grant
Jan 28
Form 4
17.10%
2.01K
Jan 31, 2013
13.75K
Grant
Jan 29
Form 4
22.81%
2.13K
Feb 02, 2012
11.48K
Grant
Jan 31
Form 4
24.28%
1.80K
Feb 03, 2011
9.20K
Grant
Feb 01
Form 4
36.97%
1.95K
Feb 02, 2010
7.24K
Grant
Feb 02
Form 4
62.52%
2.00K
Feb 05, 2009
5.21K
Grant
Feb 03
Form 4
99.62%
1.57K
Jan 31, 2008
3.16K
Grant
Jan 29
Form 4
1.56K
Feb 01, 2007
1.56K
Grant
Jan 30
Form 3
Nov 30, 2006
Showing 27 results

Seres Therapeutics, Inc.

Investor
Updated Apr 08, 2024
Form 4
60.00K
Apr 08, 2024
60.00K
Grant
Apr 04
Form 4
35.00K
Jun 23, 2023
35.00K
Grant
Jun 22
Form 4
48.00K
Jan 05, 2023
48.00K
Grant
Jan 04
Form 3
Jan 05, 2023
Showing 4 results

HELICOS BIOSCIENCES CORP

Investor
Updated May 24, 2007
Form 3
May 24, 2007
Showing 1 results